Renal Cell Carcinoma (In the pipeline)
Renal Cell Carcinoma (RCC), also known as a gurnistical tumor, is a cancer of the kidney that arises from the proximal renal tubule; it is the most prevalent type of kidney cancer in adults. Anti-Renal Cell Carcinoma detects a glycoprotein in the brush border of the proximal renal tubule, and is a useful tool for diagnosis of primary renal cell carcinomas and metastatic renal cell carcinomas. Anti-RCC has also been used to label parathyroid adenoma and some breast carcinomas, however it does not react with nephroblastoma, oncocytoma, mesoblastic nephroma, transitional cell carcinoma, or angiomyolipoma.
||Renal Cell Carcinoma
||1:100 - 1:200
- McGregor DK, et al. Am J Surg Pathol. 2001; 25:1485-92.
- Avery AK, et al. Am J Surg Pathol. 2000; 24:203-10.
- Gokden N, et al. Appl Immunohistochem Mol Morphol. 2003; 11:116-9.